The Role of Th17 in Neuroimmune Disorders: A Target for CAM Therapy. Part III

Overview

Journal Evid Based Complement Alternat Med

Specialty Rehabilitation Medicine

Date 2009 Jul 23

PMID 19622602

Citations 9

Authors

Aristo Vojdani

Jama Lambert

Gottfried Kellermann

Affiliations

Soon will be listed here.

Abstract

Abundant research has mapped the inflammatory pathways leading to autoimmunity and neuroinflammatory disorders. The latest T helper to be identified, Th17, through its proinflammatory cytokine IL-17, plays a pathogenic role in many inflammatory conditions. Today, healthcare providers have a wealth of anti-inflammatory agents from which to choose. On one hand, pharmaceutical companies market brand-name drugs direct to the public and physicians. Medical botanical knowledge, on the other hand, has been passed down from generation to generation. The demands for natural healing therapies have brought corresponding clinical and laboratory research studies to elucidate the medicinal properties of alternative practices. With a variety of options, it can be difficult to pinpoint the proper anti-inflammatory agent for each case presented. In this review, the authors highlight a vast array of anti-inflammatory medicaments ranging from drugs to vitamins and from botanicals to innate molecules. This compilation may serve as a guide for complimentary and alternative healthcare providers who need to target neuroinflammation driven by Th17 and its inflammatory cytokine IL-17. By understanding the mechanisms of anti-inflammatory agents, CAM practitioners can tailor therapeutic interventions to fit the needs of the patient, thereby providing faster relief from inflammatory complaints.

Citing Articles

Effects of acupuncture on pregnancy outcomes in women undergoing in vitro fertilization: an updated systematic review and meta-analysis.

Xu M, Zhu M, Zheng C Arch Gynecol Obstet. 2023; 309(3):775-788.

PMID: 37436463 DOI: 10.1007/s00404-023-07142-1.

The Role of Exposomes in the Pathophysiology of Autoimmune Diseases II: Pathogens.

Vojdani A, Vojdani E, Rosenberg A, Shoenfeld Y Pathophysiology. 2022; 29(2):243-280.

PMID: 35736648 PMC: 9231084. DOI: 10.3390/pathophysiology29020020.

Targeting Mitochondrial-Derived Reactive Oxygen Species in T Cell-Mediated Autoimmune Diseases.

Chavez M, Tse H Front Immunol. 2021; 12:703972.

PMID: 34276700 PMC: 8281042. DOI: 10.3389/fimmu.2021.703972.

Peripheral Inflammatory Markers Contributing to Comorbidities in Autism.

Inga Jacome M, Morales Chacon L, Cuesta H, Maragoto Rizo C, Santiesteban M, Ramos Hernandez L Behav Sci (Basel). 2016; 6(4).

PMID: 27983615 PMC: 5197942. DOI: 10.3390/bs6040029.

Natural product HTP screening for antibacterial (E.coli 0157:H7) and anti-inflammatory agents in (LPS from E. coli O111:B4) activated macrophages and microglial cells; focus on sepsis.

Mazzio E, Li N, Bauer D, Mendonca P, Taka E, Darb M BMC Complement Altern Med. 2016; 16(1):467.

PMID: 27846826 PMC: 5111180. DOI: 10.1186/s12906-016-1429-x.

References

Croom K, McCormack P . Adalimumab: in plaque psoriasis. Am J Clin Dermatol. 2009; 10(1):43-50. DOI: 10.2165/0128071-200910010-00008. View

Tikka T, Koistinaho J . Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia. J Immunol. 2001; 166(12):7527-33. DOI: 10.4049/jimmunol.166.12.7527. View

McFarland L, Surawicz C, Greenberg R, FEKETY R, Elmer G, Moyer K . A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA. 1994; 271(24):1913-8. View

Rajakangas J, Misikangas M, Paivarinta E, Mutanen M . Chemoprevention by white currant is mediated by the reduction of nuclear beta-catenin and NF-kappaB levels in Min mice adenomas. Eur J Nutr. 2008; 47(3):115-22. DOI: 10.1007/s00394-008-0704-0. View

Chiu K, Chu A, Go V, Saad M . Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr. 2004; 79(5):820-5. DOI: 10.1093/ajcn/79.5.820. View

Syrovets T, Buchele B, Krauss C, Laumonnier Y, Simmet T . Acetyl-boswellic acids inhibit lipopolysaccharide-mediated TNF-alpha induction in monocytes by direct interaction with IkappaB kinases. J Immunol. 2004; 174(1):498-506. DOI: 10.4049/jimmunol.174.1.498. View

Chowers Y, Cahalon L, Lahav M, Schor H, Tal R, Bar-Meir S . Somatostatin through its specific receptor inhibits spontaneous and TNF-alpha- and bacteria-induced IL-8 and IL-1 beta secretion from intestinal epithelial cells. J Immunol. 2000; 165(6):2955-61. DOI: 10.4049/jimmunol.165.6.2955. View

Qian L, Wei S, Zhang D, Hu X, Xu Z, Wilson B . Potent anti-inflammatory and neuroprotective effects of TGF-beta1 are mediated through the inhibition of ERK and p47phox-Ser345 phosphorylation and translocation in microglia. J Immunol. 2008; 181(1):660-8. PMC: 2741684. DOI: 10.4049/jimmunol.181.1.660. View

Dong C . TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol. 2008; 8(5):337-48. DOI: 10.1038/nri2295. View

10.

Feldmann M, Maini R . Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases. Nat Med. 2003; 9(10):1245-50. DOI: 10.1038/nm939. View

11.

Kohm A, Sanders V . Norepinephrine and beta 2-adrenergic receptor stimulation regulate CD4+ T and B lymphocyte function in vitro and in vivo. Pharmacol Rev. 2001; 53(4):487-525. View

12.

Li T, Fan G, Wang W, Li T, Yuan Y . Resveratrol induces apoptosis, influences IL-6 and exerts immunomodulatory effect on mouse lymphocytic leukemia both in vitro and in vivo. Int Immunopharmacol. 2007; 7(9):1221-31. DOI: 10.1016/j.intimp.2007.05.008. View

13.

Mahon B, Gordon S, Cruz J, Cosman F, Cantorna M . Cytokine profile in patients with multiple sclerosis following vitamin D supplementation. J Neuroimmunol. 2003; 134(1-2):128-32. DOI: 10.1016/s0165-5728(02)00396-x. View

14.

Aebischer P, Kato A . Playng defense against Lou Gehrig's disease. Sci Am. 2007; 297(5):86-93. DOI: 10.1038/scientificamerican1107-86. View

15.

Roodman G, Kurihara N, Ohsaki Y, Kukita A, Hosking D, Demulder A . Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone. J Clin Invest. 1992; 89(1):46-52. PMC: 442817. DOI: 10.1172/JCI115584. View

16.

Kopf H, de la Rosa G, Howard O, Chen X . Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3+ T regulatory cells. Int Immunopharmacol. 2007; 7(13):1819-24. PMC: 2223142. DOI: 10.1016/j.intimp.2007.08.027. View

17.

Kim C . Regulation of FoxP3 regulatory T cells and Th17 cells by retinoids. Clin Dev Immunol. 2008; 2008:416910. PMC: 2278288. DOI: 10.1155/2008/416910. View

18.

Gauldie J, Richards C, Harnish D, Lansdorp P, Baumann H . Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci U S A. 1987; 84(20):7251-5. PMC: 299269. DOI: 10.1073/pnas.84.20.7251. View

19.

Taylor M, Feng G . Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J. 1991; 5(11):2516-22. View

20.

Pochard P, Gosset P, Grangette C, Andre C, Tonnel A, Pestel J . Lactic acid bacteria inhibit TH2 cytokine production by mononuclear cells from allergic patients. J Allergy Clin Immunol. 2002; 110(4):617-23. DOI: 10.1067/mai.2002.128528. View